Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Hemodialysis Patients with Pulmonary Hypertension
NCT03763045Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Dec 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sildenafil in pulmonary hypertension (PH) (3 arms), sponsored by Ain Shams University. Primary endpoint: estimated Pulmonary Artery pressure at 3 months. Status: unknown.
02
Drugs
sildenafil
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT03763045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03763045.